Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors

Clinical trial NCT04185038 · RECRUITING

Trial details

NCT number: NCT04185038
Sponsor: Seattle Children's Hospital
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Central Nervous System Tumor Diffuse Intrinsic Pontine Glioma Diffuse Midline Glioma Ependymoma Medulloblastoma, Childhood Germ Cell Tumor Atypical Teratoid/Rhabdoid Tumor Primitive Neuroectodermal Tumor Choroid Plexus Carcinoma Pineoblastoma, Childhood Glioma

Start date: 2019-12-11
Primary completion: 2027-05-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.